All news

Kimberly-Clark closes Kenvue deal, eyes growth plan

CNBC · RSS · · AI-summarised by FinFlash

Kimberly-Clark has completed its acquisition of Kenvue, the maker of Tylenol, and now intends to improve growth and earnings across the combined business. The company has outlined a plan aimed at lifting performance following the close of the transaction. For investors, the focus shifts to execution, as the deal's value depends on delivering the promised growth and earnings gains.

Read original source

Understand the context

Published information may change. Summaries can contain errors; check the original source. Educational information only, not investment advice.